Redwoods Acquisition Corp.
Status: Deal Closed
U=S+W+R
W=S@$11.50
R=S/10
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Mar 31, 2022 |
| CEO | Jiande Chen |
| Left Lead | Chardan |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 12 + 8 + 12 |
| IPO Sector |
Energy
Carbon neutral and energy storage industries in geographies excluding China (including Hong Kong and Macau) |
| IPO Geography | Global |
| Target Company | ANEW Medical |
| Deal Announced | May 30, 2023 |
| Deal Size, $M | $97.30M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Apr 12, 2024 |
| Amendment Vote | Nov 13, 2023 |
| Closing Date | Jun 21, 2024 |
Formerly RWOD
WENA
WENA/W
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Redwoods Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 41 filings and events
- 2 underwriters
- 1 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Jiande Chen | 67 | Chief Executive Officer and Director |
| Edward Cong Wang | 39 | Chief Financial Officer and Director |
| Raymond J. Gibbs | 68 | Director |
| Wei Kwang Ng | 42 | Director |
| Hong Li | 58 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Chardan | BR | 9,950,000 | units |
| B. Riley FBR | 50,000 | ||
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.75 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.